Daiwa Securities Group
TCRT icon

Daiwa Securities Group’s Alaunos Therapeutics TCRT Stock Holding History

Daiwa Securities Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3
Closed – – 1391
2023
Q3 		$0 Hold
3
– – ﹤0.01% 1336
2023
Q2 		$0 Hold
3
– – ﹤0.01% 1347
2023
Q1 		$0 Hold
3
– – ﹤0.01% 1319
2022
Q4 		$0 Hold
3
– – ﹤0.01% 1384
2022
Q3 		$1K Hold
3
– – ﹤0.01% 1316
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1425
2022
Q1 		$0 Hold
3
– – ﹤0.01% 1415
2021
Q4 		$0 Hold
3
– – ﹤0.01% 1443
2021
Q3 		$1K Hold
3
– – ﹤0.01% 1286
2021
Q2 		$1K Hold
3
– – ﹤0.01% 1215
2021
Q1 		$1K Hold
3
– – ﹤0.01% 1226
2020
Q4 		$1K Buy
+3
New +$1.19K ﹤0.01% 1205

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Daiwa Securities Group's TCRT Position: Q4 2023 in Review

Daiwa Securities Group sold out of Alaunos Therapeutics (TCRT) in Q4 2023, closing a stake of 3 shares.

Daiwa Securities Group first reported a position in TCRT in Q4 2020 and held it in 12 quarters. The position peaked at $1K in Q3 2022. 82 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.

  • Daiwa Securities Group reported no remaining Alaunos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 3 Alaunos Therapeutics shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Alaunos Therapeutics in Q4 2020 and held it in 12 quarters.
  • Daiwa Securities Group's Alaunos Therapeutics position peaked at $1K in Q3 2022.
  • 82 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.